2MM USA Corporation – Trademark Portfolio
Entity Type: 03
2MM USA Corporation holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include 2MM, 2 MM, ADECAST, IVECATH, and ALCOKLIN. The owner is based in MIAMI, FL.
2150 NW 93 Avenue
MIAMI, FL 33172
Showing of trademarks Trademarks
Trademark Classifications
2MM USA Corporation's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does 2MM USA Corporation have?
2MM USA Corporation has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does 2MM USA Corporation file in?
2MM USA Corporation files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are 2MM USA Corporation's most well-known trademarks?
2MM USA Corporation's registered trademark portfolio includes well-known marks such as 2MM, 2 MM, ADECAST, IVECATH, and ALCOKLIN. These are among 6 currently registered trademarks in the portfolio.
What is 2MM USA Corporation's trademark registration success rate?
2MM USA Corporation has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.